Oshid Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 31 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 7.81%
- Profit Growth -3.07%
- Ebitda -11.52%
- Net Worth 12.83%
- Total Assets -27.74%
About Oshid Pharmaceuticals
Oshid Pharmaceuticals Pvt Ltd (OPPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 August 1993 and has a history of 31 years and five months. Its registered office is in Punjab, Punjab.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Aman Kumar and Vipan Kalia serve as directors at the Company.
Company Details
- LocationPunjab, Punjab
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24231PB1993PTC013631
- Company No.
013631
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Aug 1993
- Date of AGM
30 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
What products or services does Oshid Pharmaceuticals Pvt Ltd offer?
Oshid Pharmaceuticals Pvt Ltd offers a wide range of products and services, including Flavours & Aromatics, Vinegar, Common Disease Medicines, Pharmaceutical Capsules, Ayurvedic,Herbal Products & Medicine, Ayurvedic Medicine, Nutraceuticals & Dietary Supplements, Mineral Supplement, Ayurvedic Herbal Syrups & Tonics, Ayurvedic, Herbal Oils and Cosmetics.
Who are the key members and board of directors at Oshid Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aman Kumar  | Director | 30-Jun-2008 | Current |
| Vipan Kalia | Director | 19-Aug-1993 | Current |
Financial Performance of Oshid Pharmaceuticals.
Oshid Pharmaceuticals Pvt Ltd, for the financial year ended 2022, experienced modest growth in revenue, with a 7.81% increase. The company also saw a slight decrease in profitability, with a 3.07% decrease in profit. The company's net worth Soared by an impressive increase of 12.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Oshid Pharmaceuticals?
In 2021, Oshid Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shane Healthcare Private LimitedVipan Kalia is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Oshid Pharmaceuticals?
Unlock and access historical data on people associated with Oshid Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Oshid Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oshid Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
